Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02708641
Title A Phase II Study of Pembrolizumab as Post-Remission Treatment of Patients 60 With AML
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Michael Boyiadzis
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.